"HIV治療" の関連情報検索結果
Single-shot HIV treatment suppresses virus 10,000-fold for months, animal study finds - Livescien...
Single-shot HIV treatment suppresses virus 10,000-fold for months, animal study finds Livescience.com
The search for an HIV cure - aidsmap
The search for an HIV cure aidsmap
WHO: access to HIV medicines severely impacted by COVID-19 as AIDS response stalls - World Health...
WHO: access to HIV medicines severely impacted by COVID-19 as AIDS response stalls World Health Organization (WHO)
UVA Health Effort Aims to Improve HIV Care Across America - UVA Health Newsroom
UVA Health Effort Aims to Improve HIV Care Across America UVA Health Newsroom
Amidst stalled HIV prevention, WHO supports new long-acting prevention drug cabotegravir - UN News
Amidst stalled HIV prevention, WHO supports new long-acting prevention drug cabotegravir UN News
Monthly HIV injection could free patients from gruelling drug regimen - Nature.com
Monthly HIV injection could free patients from gruelling drug regimen Nature.com
U.S. FDA approves Gilead's long-acting HIV drug Sunlenca - Reuters
U.S. FDA approves Gilead's long-acting HIV drug Sunlenca Reuters
Classes of Antiretrovirals and How They Work - Verywell Health
Classes of Antiretrovirals and How They Work Verywell Health
Will post-treatment controllers guide us towards an HIV cure? - aidsmap
Will post-treatment controllers guide us towards an HIV cure? aidsmap
So far, Poland has seen fewer Ukrainian refugees with HIV than expected - aidsmap
So far, Poland has seen fewer Ukrainian refugees with HIV than expected aidsmap
Two-thirds of people living with HIV would like to try injectable treatment, according to Europea...
HIV services in Ukraine resilient but starting to feel the strain - aidsmap
HIV services in Ukraine resilient but starting to feel the strain aidsmap
SEARCH study finds universal 'test and treat' reduces infant HIV - aidsmap
SEARCH study finds universal 'test and treat' reduces infant HIV aidsmap
After viral rebound, dolutegravir-based treatment more likely to suppress HIV - aidsmap
After viral rebound, dolutegravir-based treatment more likely to suppress HIV aidsmap
European AIDS Treatment Group documents the impact of COVID on HIV services throughout Europe - a...
European AIDS Treatment Group documents the impact of COVID on HIV services throughout Europe aidsmap
Four days on, three days off HIV treatment as effective as continuous therapy, French study finds...
Four days on, three days off HIV treatment as effective as continuous therapy, French study finds aidsmap
Second-line treatment nearly nine times more expensive than first-line in upper-middle income cou...
Islatravir plus doravirine remains effective at 96 weeks - aidsmap
Islatravir plus doravirine remains effective at 96 weeks aidsmap
Novel, twice-a-year injected drug suppresses multidrug-resistant HIV in most patients on failing ...
HIV infections lowered by 30% in universal testing and treatment study - aidsmap
HIV infections lowered by 30% in universal testing and treatment study aidsmap
Poorer HIV care outcomes for those using alcohol and drugs in sub-Saharan African countries - aid...
Poorer HIV care outcomes for those using alcohol and drugs in sub-Saharan African countries aidsmap
What are the roles of TAF and integrase inhibitors in weight gain? - aidsmap
What are the roles of TAF and integrase inhibitors in weight gain? aidsmap
GSK snags first-in-class FDA nod for Rukobia to treat HIV patients who have few options - FierceP...
GSK snags first-in-class FDA nod for Rukobia to treat HIV patients who have few options FiercePharma
Prolonged HIV suppression is possible using ibalizumab, analysis of highly drug-resistant people ...
Further evidence that recycling tenofovir in second-line treatment is effective - aidsmap
Further evidence that recycling tenofovir in second-line treatment is effective aidsmap
South Africa: dropping out of HIV care is deadly - aidsmap
US regulators approve new two-drug combination pill for HIV - aidsmap
US regulators approve new two-drug combination pill for HIV aidsmap
Earlier treatment and higher CD4 counts linked to smaller HIV reservoir - aidsmap
Earlier treatment and higher CD4 counts linked to smaller HIV reservoir aidsmap
Unique transgender vulnerabilities require tailored and specific interventions - aidsmap
Unique transgender vulnerabilities require tailored and specific interventions aidsmap
Oral six-month treatment for MDR-TB is safe and effective in people with HIV - aidsmap
Oral six-month treatment for MDR-TB is safe and effective in people with HIV aidsmap
Reappearance of HIV in "Mississippi Baby" poses questions for early treatment - aidsmap
Reappearance of HIV in "Mississippi Baby" poses questions for early treatment aidsmap
Integrase inhibitors do not raise cardiovascular risk in people starting HIV treatment - aidsmap
Integrase inhibitors do not raise cardiovascular risk in people starting HIV treatment aidsmap
Dolutegravir-based HIV treatment is the safest and most effective choice for pregnant women - aid...
Dolutegravir-based HIV treatment is the safest and most effective choice for pregnant women aidsmap
Gene therapy or immunotherapy: which approach is more likely to deliver a cure for HIV? - aidsmap
Gene therapy or immunotherapy: which approach is more likely to deliver a cure for HIV? aidsmap
Dolutegravir recommended for all in new World Health Organization guidelines - aidsmap
Dolutegravir recommended for all in new World Health Organization guidelines aidsmap
South Africa saves $326 million on dolutegravir - aidsmap
Using marijuana for breast cancer: How it works, safety, and benefits - Medical News Today
Using marijuana for breast cancer: How it works, safety, and benefits Medical News Today
ADVANCE trial shows dolutegravir is highly effective in South Africa - aidsmap
ADVANCE trial shows dolutegravir is highly effective in South Africa aidsmap
Why I injected myself with an untested gene therapy - BBC
Lenacapavir shows continued promise for first-line treatment and highly resistant HIV (Mandarin) ...
Lenacapavir shows continued promise for first-line treatment and highly resistant HIV (Mandarin) aidsmap
Test-and-treat leads to sustained fall in hepatitis C in Swiss gay men with HIV (Mandarin) - aidsmap
Test-and-treat leads to sustained fall in hepatitis C in Swiss gay men with HIV (Mandarin) aidsmap